Volume 28, Number 6—June 2022
Research Letter
Expansion of L452R-Positive SARS-CoV-2 Omicron Variant, Northern Lombardy, Italy
Table
Patient no. | Date | Age, y/sex | Symptoms | NextStrain | PANGOlin | GISAID accession no. |
---|---|---|---|---|---|---|
1 | 2021 Dec 3 | 41/F | NA | 21K | BA.1 | EPI_ISL_9319568 |
2 | 2022 Jan 3 | 80/M | Fever | 21K | BA.1 | EPI_ISL_9306683 |
3 | 2022 Jan 3 | 43/F | Chest pain, diarrhea | 21K | BA.1 | EPI_ISL_9306774 |
4 | 2022 Jan 3 | 64/M | Fever and dyspnea | 21K | BA.1 | EPI_ISL_9319248 |
5 | 2022 Jan 3 | 52/F | NA | 21K | BA.1 | EPI_ISL_9306775 |
6 | 2022 Jan 3 | 55/M | Syncope (multiple sclerosis) | 21K | BA.1 | EPI_ISL_9306776 |
7 | 2022 Jan 3 | 65/F | NA | 21K | BA.1 | EPI_ISL_9322734 |
8 | 2022 Jan 3 | 48/F | Headache | 21M | None | EPI_ISL_9323426 |
9 | 2022 Jan 3 | 31/F | NA | 21M | None | EPI_ISL_9319319 |
10 | 2022 Jan 3 | 37/M | NA | 21K | BA.1 | EPI_ISL_9319384 |
11 | 2022 Jan 3 | 14/M | NA | 21K | BA.1 | EPI_ISL_9323297 |
12 | 2022 Jan 3 | 53/M | NA | 21K | BA.1 | EPI_ISL_9323497 |
13 | 2022 Jan 3 | 73/M | NA | 21M | BA.3 | EPI_ISL_9324184 |
14 | 2022 Jan 3 | 78/M | None | 21K | BA.1 | EPI_ISL_9306777 |
15 | 2022 Jan 3 | 82/F | None | 21K | BA.1 | EPI_ISL_9307474 |
16 | 2022 Jan 12 | 70/F | Dyspnea | 21K | BA.1 | EPI_ISL_9319456 |
17 | 2022 Jan 17 | 87/M | Right pneumonia | 21K | BA.1 | EPI_ISL_9324185 |
18 | 2022 Jan 19 | 92/M | NA | 21K | BA.1 | EPI_ISL_9323128 |
19 | 2022 Jan 19 | 2/F | NA | 21K | BA.1.1 | EPI_ISL_9309942 |
20 | 2022 Jan 19 | 47/F | NA | 21K | BA.1.1 | EPI_ISL_9323348 |
21 | 2022 Jan 19 | 45/M | NA | 21M | BA.1 | EPI_ISL_9324374 |
22 | 2022 Jan 19 | 26/M | NA | 21M | None | EPI_ISL_9324445 |
23 | 2022 Jan 24 | 23/M | Fever (multiple sclerosis) | 21K | BA.1.1 | EPI_ISL_9310402 |
24 | 2022 Jan 24 | 22/F | NA | 21K | BA.1 | EPI_ISL_9323222 |
25 | 2022 Jan 24 | 1/F | Cough | 20B | BA.3 | EPI_ISL_9324518 |
*NA, not available.
Page created: April 06, 2022
Page updated: May 22, 2022
Page reviewed: May 22, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.